Lyric, a trusted leader in healthcare decision intelligence for payment accuracy, announces its acquisition of Concert, a precision health payment accuracy leader with proprietary technology for translating machine-readable policies into real-time decisions. Concert is a healthcare technology company enabling cost-effective access to diagnostics and therapeutics by harmonizing evidence, policy, and payment. Founded in 2010 to bring transparency and efficiency to genetic testing, Concert now offers the definitive precision health payment accuracy platform.
Read the full article: Lyric Acquires Concert to Advance Healthcare Decision Intelligence and Expand the Lyric42 Platform //
Source: https://www.businesswire.com/news/home/20260715415003/en/Lyric-Acquires-Concert-to-Advance-Healthcare-Decision-Intelligence-and-Expand-the-Lyric42-Platform